Integrated Biopharma Price on October 23, 2023
INBPDelisted Stock | USD 0.33 0.00 0.00% |
If you're considering investing in Integrated OTC Stock, it is important to understand the factors that can impact its price. As of today, the current price of Integrated Biopharma stands at 0.33, as last reported on the 30th of November, with the highest price reaching 0.33 and the lowest price hitting 0.32 during the day. We have found twenty-two technical indicators for Integrated Biopharma, which you can use to evaluate the volatility of the firm. Please check out Integrated Biopharma's Market Risk Adjusted Performance of (0.39), standard deviation of 4.05, and Risk Adjusted Performance of (0.02) to validate if the risk estimate we provide is consistent with the expected return of 0.0%.
Integrated OTC Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Integrated |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
INBP |
Based on monthly moving average Integrated Biopharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Integrated Biopharma by adding Integrated Biopharma to a well-diversified portfolio.
Integrated Biopharma Valuation on October 23, 2023
It is possible to determine the worth of Integrated Biopharma on a given historical date. On October 23, 2023 Integrated was worth 0.33 at the beginning of the trading date compared to the closed value of 0.33. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Integrated Biopharma otc stock. Still, in general, we apply an absolute valuation method to find Integrated Biopharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Integrated Biopharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Integrated Biopharma's related companies.
Open | High | Low | Close | Volume | |
0.33 | 0.33 | 0.33 | 0.33 | 30,000 | |
07/21/2023 | 0.33 | 0.33 | 0.32 | 0.33 | 46,100 |
0.33 | 0.33 | 0.32 | 0.33 | 0.00 |
Backtest Integrated Biopharma | | | Integrated Biopharma History | | | Integrated Biopharma Valuation | Previous | Next |
Integrated Biopharma Trading Date Momentum on October 23, 2023
On November 30 2024 Integrated Biopharma was traded for 0.33 at the closing time. The top price for the day was 0.33 and the lowest listed price was 0.32 . There was no trading activity during the period 0.0. Lack of trading volume on November 30, 2024 did not cause price change. The trading delta at closing time against the current closing price is 0.00% . |
Integrated Biopharma Fundamentals Correlations and Trends
By evaluating Integrated Biopharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Integrated Biopharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Integrated financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Integrated Biopharma OTC Stock history
Integrated Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Integrated is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Integrated Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Integrated Biopharma stock prices may prove useful in developing a viable investing in Integrated Biopharma
Integrated BioPharma, Inc., together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey. Integrated Biopharma operates under Packaged Foods classification in the United States and is traded on OTC Exchange. It employs 147 people.
Integrated Biopharma OTC Stock Technical Analysis
Integrated Biopharma technical otc stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, otc market cycles, or different charting patterns.
Price Boundaries
Integrated Biopharma Period Price Range
Low | November 30, 2024
| High |
0.00 | 0.00 |
Integrated Biopharma cannot be verified against its exchange. Please verify the symbol is currently traded on OTCQX Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Integrated Biopharma November 30, 2024 Market Strength
Market strength indicators help investors to evaluate how Integrated Biopharma otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Integrated Biopharma shares will generate the highest return on investment. By undertsting and applying Integrated Biopharma otc stock market strength indicators, traders can identify Integrated Biopharma entry and exit signals to maximize returns
Integrated Biopharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Integrated Biopharma's price direction in advance. Along with the technical and fundamental analysis of Integrated OTC Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Integrated to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.02) | |||
Jensen Alpha | (0.19) | |||
Total Risk Alpha | (0.82) | |||
Treynor Ratio | (0.40) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Integrated Biopharma information on this page should be used as a complementary analysis to other Integrated Biopharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Consideration for investing in Integrated OTC Stock
If you are still planning to invest in Integrated Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Integrated Biopharma's history and understand the potential risks before investing.
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume |